Fonte: Anvisa Data destaca avanços regulatórios, fortalecimento do SUS e ampliação do acesso a terapias biológicas no Paí...
Walker Lahmann, executive director of Eurofarma and member of the Board of Directors of PróGenéricos, was sworn in as...
The generic drugs market continues to expand in the North and recorded growth of over 10% in 2025. In all, it was...
The generic drug market in the Midwest grew by 6.45% in 2025, surpassing the national average and consolidating the region's...
With a 53% increase in sales, generic drugs are consolidating their position as the main option for treating hypercholesterolem...
Take part in Biosimilars LatAm - Brazil 2025, which will take place on August 12 and 13 in São Paulo. This forum will bring together...
Like PróGenéricos in Brazil, the International Generic and Biosimilar Association (IGBA) works in the field of...
Unlike common side effects, it is dose-independent and can appear even with previous use of the drug without any...
Fresenius Kabi has just received approval from Anvisa (National Health Surveillance Agency) for Tyenne, the first biologic...